Healthcare and Medical
Healthcare and Medical
home | healthcare and medical | company profile
Optimer Pharmaceuticals Inc - Premium Company Profile (Datamonitor)
- Market: Healthcare and Medical
- Published Date: 22/04/2008
- Report Title: Optimer Pharmaceuticals Inc - Premium Company Profile
- Table of Contents: View Table of Contents
- Report Type: Company Profile
- Country: Global
- Number of Pages: 40
Introduction
Optimer is a biopharmaceutical company focused on the discovery, development and global commercialization of anti-infective products for the treatment of serious infectious diseases. The Company currently has two late stage anti-infective product candidates, OPT-80 (Difimicin) and Prulifloxacin, at Phase III trials.
Scope
Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies
Highlights
Optimer in-licensed Difimicin from Par Pharmaceuticals and Prulifloxacin from Nippon Shinyaku. In addition, the company has acquired OPopS technology from The Scripps Research Institute. Utilizing the OPopS technology the company is developing Difimicin and other internal products.
Optimer recognized its historical revenues from 2004. During 2004-2006, total revenue growth was nearly constant derived from sole revenue stream, license fees, collaboration and others. The significant decline in revenues from $2 in 2005 to $1 million in 2006 was due to the lowered Small Business Innovation Research Program (SBIR) grants.
Optimer’s total revenues during 2006-2010 are forecasted with an absolute growth of +$97 million with sales increasing from $1 million to $98 million grows at a CAGR of 21%. The increase was primarily due to the forecasted revenues from Difimicin and Prulifloxacin.
Reasons to Purchase
Access all the important information and analysis on the company in a single report Understand company’s strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company’s adjusted five year financial data along with key ratios and market capitalization
Scope
Highlights
Reasons to Purchase
Purchase Information
There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses RBSWorldpay.
Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Orders that are deliverable via email which are taken outside of working hours will be delivered next business day.
Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.
